Sonoma Pharmaceuticals (SNOA) Net Margin (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Net Margin came in at 10.45% in Q1 2026, up 1022.0% year-on-year from 0.93% in Q1 2025, and up 44.52% quarter-over-quarter from 18.83% in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Net Margin (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Net Margin history runs 17 years deep, the most recent figure standing at 10.45% for Q1 2026.
- On a quarterly basis, Net Margin rose 1022.0% year-over-year to 10.45% in Q1 2026; TTM through Mar 2026 was 16.26%, a 794.0% increase from a year earlier, with the FY2026 full-year figure at 16.26%, up 794.0% from the prior year.
- Net Margin improved to 10.45% in Q1 2026 per SNOA's latest filing, from 18.83% in the prior quarter.
- Across five years, Net Margin topped out at 9.53% in Q3 2025 and bottomed at 65.86% in Q4 2022.
- The 5-year median for Net Margin is 29.06% (2023), against an average of 30.22%.
- Across the five-year window, Net Margin slumped 2786 bps in 2022 and jumped 3827 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 65.86% in 2022, then surged by 58 bps to 27.6% in 2023, then climbed by 6 bps to 26.04% in 2024, then rose by 28 bps to 18.83% in 2025, then soared by 45 bps to 10.45% in 2026.
- Per Business Quant, the three latest SNOA Net Margin figures stand at 10.45% (Q1 2026), 18.83% (Q4 2025), and 9.53% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -10.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.45% |
| Dec 31, 2025 | -18.83% |
| Sep 30, 2025 | -9.53% |
| Jun 30, 2025 | -30.91% |
| Mar 31, 2025 | -20.67% |
| Dec 31, 2024 | -26.04% |
| Sep 30, 2024 | -17.04% |
| Jun 30, 2024 | -33.71% |
| Mar 31, 2024 | -31.03% |
| Dec 31, 2023 | -27.60% |
| Sep 30, 2023 | -54.34% |
| Jun 30, 2023 | -41.38% |
| Mar 31, 2023 | -43.40% |
| Dec 31, 2022 | -65.86% |
| Sep 30, 2022 | -30.53% |
| Jun 30, 2022 | -22.27% |
| Sep 30, 2021 | -2.67% |
| Jun 30, 2021 | -29.80% |
| Mar 31, 2021 | -10.57% |
| Dec 31, 2020 | -0.49% |